DrugPatentWatch Database Preview
Genentech Inc Company Profile
Summary for Genentech Inc
| Patents: | 40 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| BLAs: | 3 |
| Patent Litigation for Genentech Inc: | See patent lawsuits for Genentech Inc |
US Patents for Genentech Inc
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech Inc | OCREVUS | ocrelizumab | INJECTABLE;INJECTION | 761053 | 001 | 2017-03-28 | 9,982,302 | Genentech, Inc. (South San Francisco, CA) | ➤ Sign Up | RX | search | |
| Genentech Inc | OCREVUS | ocrelizumab | INJECTABLE;INJECTION | 761053 | 001 | 2017-03-28 | 9,879,325 | ASSISTANCE PUBLIQUE--HOPITAUX DE PARIS (Paris, FR) UNIVERSITE PARIS DIDEROT (PARIS VII) (Paris, FR) UNIVERSITE DE NICE--SOPHIA ANTIPOLIS (Nice, FR) INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (Paris, FR) | ➤ Sign Up | RX | search | |
| Genentech Inc | OCREVUS | ocrelizumab | INJECTABLE;INJECTION | 761053 | 001 | 2017-03-28 | 9,862,772 | BEUTSCHES RHEUMA-FORSCHUNGSZENTRUM BERLIN (DRFZ) (Berlin, DE) | ➤ Sign Up | RX | search | |
| Genentech Inc | OCREVUS | ocrelizumab | INJECTABLE;INJECTION | 761053 | 001 | 2017-03-28 | 9,862,767 | Alexion Pharmaceuticals, Inc. (New Haven, CT) | ➤ Sign Up | RX | search | |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
Similar Applicant Names
Companies are sometimes listed under multiple names.
This search can help find similar names.
This search can help find similar names.
